(Q74348259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A A Kroon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M A van't Hof

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P N Demacker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A F Stalenhoef

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

519-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

LDL-apheresis: results of longterm treatment and vascular outcome

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Regression of atherosclerosis in humans by lowering serum cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Plasma exchange for hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia effects of plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

No evidence for feedback inhibition of hepatic apolipoprotein B (apo B) production after extracorporeal low density lipoprotein precipitation as determined by [1-13C]leucine infusion in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Serum plant sterols and their relation to cholesterol absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Non-steady-state kinetics of low density lipoproteins in man: studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Cholesterol biosynthesis in normocholesterolemic patients after cholesterol removal by plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: evidence for a threshold effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900371-3

10.1016/S0021-9150(00)00371-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998482%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference